Initial Evaluation of [(18)F]FAPI-74 PET for Various Histopathologically Confirmed Cancers and Benign Lesions

The (18)F-labeled fibroblast activation protein inhibitor (FAPI) [(18)F]FAPI-74 has the benefit of a higher synthetic yield and better image resolution than (68)Ga-labeled FAPI. We preliminarily evaluated the diagnostic performance of [(18)F]FAPI-74 PET in patients with various histopathologically c...

Descripción completa

Detalles Bibliográficos
Autores principales: Watabe, Tadashi, Naka, Sadahiro, Tatsumi, Mitsuaki, Kamiya, Takashi, Kimura, Toru, Shintani, Yasushi, Abe, Kaori, Miyake, Tomohiro, Shimazu, Kenzo, Kobayashi, Shogo, Kurokawa, Yukinori, Eguchi, Hidetoshi, Doki, Yuichiro, Inohara, Hidenori, Kato, Hiroki, Mori, Yuriko, Cardinale, Jens, Giesel, Frederik L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Nuclear Medicine 2023
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394310/
https://www.ncbi.nlm.nih.gov/pubmed/37268427
http://dx.doi.org/10.2967/jnumed.123.265486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394310/
https://www.ncbi.nlm.nih.gov/pubmed/37268427
http://dx.doi.org/10.2967/jnumed.123.265486

Ejemplares similares